Outpatient Physical Therapy Intervention in Subjects With Parkinson's Disease Currently Using APOKYN®

NCT02549573 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

13

Enrollment

INDUSTRY

Sponsor class

Stopped Subject enrollment is unsatisfactory

Conditions

Parkinson's Disease
Motor Symptoms

Interventions

DRUG: APOKYN
BEHAVIORAL: Physical Therapy

Sponsor

MDD US Operations, LLC a subsidiary of Supernus Pharmaceuticals